Clinical outcome of percutaneous thrombectomy of dialysis access thrombosis by an interventional nephrologist.
10.1016/j.krcp.2014.10.004
- Author:
Hyung Seok LEE
1
;
Pyoung Ju PARK
Author Information
1. Department of Nephrology, Hanmaeum Hospital, Jeju, Korea. pcsacred@gmail.com
- Publication Type:Original Article
- Keywords:
Endovascular procedures;
Hemodialysis;
Percutaneous transluminal angioplasty;
Thrombectomy;
Thrombosis
- MeSH:
Angioplasty;
Arteriovenous Fistula;
Dialysis*;
Endovascular Procedures;
Humans;
Kidney Diseases;
Korea;
Renal Dialysis;
Thrombectomy*;
Thrombosis*;
Transplants
- From:Kidney Research and Clinical Practice
2014;33(4):204-209
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Traditionally, the treatment of a thrombosed dialysis access in hemodialysis patients in Korea has been primarily performed by vascular surgeons and interventional radiologists. The objective of this study was to evaluate the outcome of percutaneous thrombectomy procedures performed by an interventional nephrologist. METHODS: From October 2010 to May 2014, 75 consecutive percutaneous thrombectomies were performed on 42 patients treated with maintenance hemodialysis. All percutaneous thrombectomy procedures were performed by an interventional nephrologist in a single hospital in Jeju, Korea. The thrombosed arteriovenous graft and arteriovenous fistula were declotted by thromboaspiration mechanical thrombectomy or pharmacomechanical thrombolysis. Kaplan-Meier survival analysis was performed to analyze the primary and secondary patency after the initial successful thrombectomy. Success and complication rates were identified and compared with the recommendations of the Kidney Disease Dialysis Outcomes Quality Initiative (KDOQI) guideline. RESULTS: The overall clinical success rate was 89.3% (67/75). In the successful cases, the postintervention primary (unassisted) patency rates at 30 days, 90 days, and 180 days were 79.9%, 56.6%, and 25.6%, respectively. The secondary patency rates at 30 days, 90 days, and 180 days were 92.2%, 85.7%, and 83.7%, respectively. There were no major complications, and all complications were treated successfully during the procedure. CONCLUSION: The clinical success rate and primary patency rate at 3 months exceeded the recommendations of the KDOQI guideline, and were comparable to that of other reports. Percutaneous thrombectomy by an interventional nephrologist was safe and effective.
